Julian P Tuazon Selected Research

ST 1435

1/2019	Beyond contraception and hormone replacement therapy: Advancing Nestorone to a neuroprotective drug in the clinic.
1/2019	Reprint of: Beyond contraception and hormone replacement therapy: Advancing Nestorone to a neuroprotective drug in the clinic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julian P Tuazon Research Topics

Disease

10	Stroke (Strokes) 01/2020 - 01/2018
4	Ischemic Stroke 01/2020 - 01/2018
4	Infarction (Infarctions) 01/2020 - 01/2019
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2019 - 01/2019
2	Central Nervous System Diseases (CNS Diseases) 01/2019 - 01/2019
1	Epilepsy (Aura) 01/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Disease Progression 10/2019
1	Brain Ischemia (Cerebral Ischemia) 04/2019
1	Fetal Alcohol Spectrum Disorders 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Hypothermia 12/2018
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2018
1	Brain Injuries (Brain Injury) 12/2018

Drug/Important Bio-Agent (IBA)

2	Therapeutic UsesIBA 01/2020 - 12/2018
2	Pharmaceutical PreparationsIBA 10/2019 - 01/2019
2	Progestins (Progestagens)IBA 01/2019 - 01/2019
2	ST 1435IBA 01/2019 - 01/2019
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	CorticosteroneIBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	rhyncophyllineIBA 01/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019
1	Neuroprotective AgentsIBA 04/2019
1	Biological ProductsIBA 01/2019
1	Levodopa (L Dopa)FDA LinkGeneric 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	CytokinesIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA 12/2018
1	Leucine EnkephalinIBA 12/2018
1	Alanine (L-Alanine)FDA Link 12/2018
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2020 - 12/2018
4	Transplantation 01/2020 - 01/2019
1	Intravenous Administration 01/2020
1	Stem Cell Transplantation 01/2019
1	Induced Hypothermia 12/2018